D. Krupa

Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review

K. Ikeda, Y. Kaneko, Masayo Sato, 2018, Modern rheumatology.

In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin

D. Schmatz, J. Balkovec, K. Bartizal, 1992, Antimicrobial Agents and Chemotherapy.

Leg ulcers due to hyperhomocysteinemia Leg ulcers due to hyperhomocysteinemia Leg ulcers due to hyperhomocysteinemia Leg ulcers due to hyperhomocysteinemia Leg ulcers due to hyperhomocysteinemia

D. Krupa, Syed Akhib, D. Shankar, 2006 .

Real-life Treatment Patterns and Medication Costs in Patients with Hypertension Treated with Ramipril Monotherapy or Ramipril Loose and Fixed Combinations in Poland

M. Czech, D. Krupa, Z. Jasiński, 2015 .

Impact of COVID-19 Pandemic on the Use of Antidepressant and Antianxiety Pharmaceuticals as Well as Sick Leave in Poland

M. Czech, J. Pinkas, A. Mosiołek, 2022, International journal of environmental research and public health.

Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

J. Smith, C. Gill, K. Bartizal, 1995, Antimicrobial agents and chemotherapy.

LEPROSY: DISEASE PREVAILING FROM PAST TO PRESENT

N. Manasa, D. Krupa, A. Rao, 2012 .

DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF RISPERIDONE BY MBTH

S. Archana, M. Hema, D. Krupa, 2013 .

The Potential to Reduce Patient Co-Payment and the Public Payer Spending in Poland through an Optimised Implementation of the Generic Substitution: The Win-Win Scenario Suggested by the Real-World Big Data Analysis

P. Kardas, P. Lewek, Filip Urbański, 2021, Pharmaceutics.